MONDAY, Dec. 13, 2021 (HealthDay News) — A gene therapy that could provide a permanent cure for sickle cell disease continues to show success through a third wave of patients, researchers report. The therapy, LentiGlobin, restored normal blood function in 35 sickle cell patients who had the one-time procedure, accordingContinue Reading

MONDAY, Dec. 13, 2021 (HealthDay News) — You can’t always choose who operates on you, especially in an emergency, but the sex of your surgeon shouldn’t matter, should it? It just may, according to a Canadian study of 1.3 million people. It reported that women who underwent common elective orContinue Reading

MONDAY, Dec. 13, 2021 (HealthDay News) — Older adults have a higher risk of delirium after hip and knee surgery if they’re taking anxiety, depression or insomnia drugs, researchers say. “Our findings show that different classes of medicine are riskier than others when it comes to causing delirium after surgery,Continue Reading

FRIDAY, Dec. 10, 2021 (HealthDay News) — Children with the rare cancer neuroblastoma often succumb to the disease despite aggressive treatment. But researchers have found that adding an experimental antibody to that treatment, right off the bat, may improve their outlook. Of 64 children treated with the antibody in aContinue Reading

FRIDAY, Dec. 10, 2021 (HealthDay News) — “Fights off tumors and alleviates symptoms of chemotherapy,” one vape’s advertising claims, while another is touted as an “asthma remedy, ADHD remedy, and dementia treatment.” Don’t believe the hype. Despite claims that certain vaping products may alleviate health problems, there’s no proof thatContinue Reading

FRIDAY, Dec. 10, 2021 (HealthDay News) — U.S. operating rooms got busy once again soon after the first round of pandemic shutdowns, according to a study that challenges the widely held belief that operations have been curtailed indefinitely during the age of COVID-19. “It’s an untold story,” said senior studyContinue Reading

THURSDAY, Dec. 9, 2021 (HealthDay News) — Children with hard-to-control asthma may get relief from adding an injectable antibody drug to their standard treatment, a clinical trial has found. The drug, called dupilumab (Dupixent), has been available for several years to treat stubborn asthma in adults and teenagers. Based onContinue Reading

THURSDAY, Dec. 9, 2021 (HealthDay News) — What do all the microbes living rent-free in your gut have to do with disease risk? Perhaps a lot. A groundbreaking analysis of decades-old stool and blood samples from the early AIDS epidemic suggests that men who had high levels of inflammation-causing bacteriaContinue Reading

THURSDAY, Dec. 9, 2021 (HealthDay News) — A condition called “diabetic retinopathy” often threatens the vision of adults with diabetes, but new research suggests that kids with type 2 diabetes may be particularly vulnerable to the vision-robbing complication. In fact, these kids were nearly twice as likely to develop theContinue Reading